The readers of Inflammation Research will all be aware of the cardinal signs of inflammation: swelling, redness, heat, pain, described by the ancient Greek physician Celsus, and subsequently complemented by the symptom of loss of function. Over the last few decades, our understanding of the generation of these inflammatory signs by soluble mediators, actions at cell surface receptors, signalling processes and gene expression has expanded dramatically. Less work has been done, however, on the way in which the symptomatic processes of inflammation are able to interact with the molecular pathways involved. We know that heat is able to stimulate pain receptors and cause tissue injury and that other local variables, such as pH and osmotic pressure, affect pain and swelling. But how do such conditions modify specific molecular processes?
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In the current issue of Inflammation Research, two articles are published that address this question. The first, by Neelands et al, addresses the effect of temperature on vanilloid receptor-1 (TRPV1)-induced dorsal root ganglionmediated pain responses. TRPV1 is activated by the extract of chili, capsaicin, by several endogenous lipids and also by elevated temperature and acidic pH, but the discrimination between these different stimuli is still under investigation. In the article published here, it is shown that capsaicin and the endogenous TRPV1 agonist, anandamide, markedly enhance sensitivity of TRPV1 receptors to elevated temperature, demonstrating crucial synergism between these molecular and local environmental variables.
The second article, by Abolhassani et al, reports on the stimulation of inflammatory mediator production from colorectal and bladder cell lines by hyperosmotic solutions. This response was associated with nuclear factor-kappa B activation and degradation of inhibitor of kappa B kinasegamma. Intriguingly, all these responses could be related to a simple change in the methylation of protein phosphatase A. The possibility arises that an increase in osmotic pressure, resulting from an increased protein concentration at inflamed sites, may be sufficient to drive a variety of complex inflammatory mechanisms.
